Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06874322 · ClinicalTrials.gov registry record · NA
Voiceitt for People With Impairments in Speech
A NA study of Speech Disorder and Speech Impairment, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06874322 is a NA study of Speech Disorder and Speech Impairment that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 20 participants, below the 322-participant average among 3 other Speech Disorder trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06874322, a NA study of Speech Disorder and Speech Impairment, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this pilot study is to evaluate the feasibility and preliminary effectiveness of the Voiceitt app in improving communication for individuals with speech impairments due to conditions such as cerebral palsy (CP), stroke, Amyotrophic Lateral Sclerosis (ALS), or Parkinson's disease.
Conditions Studied
Interventions
- OTHER Voiceitt
Study Locations (1)
Pennsylvania
- Center for Assistive Technology - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-06-25 |
| Est. Completion | 2026-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06874322
The ClinicalTrials.gov registry entry for NCT06874322 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 322-participant average among 3 other Speech Disorder trials with a reported enrollment target (94% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Speech Disorder appearing as the primary indexed condition, and to 1 intervention - of which Voiceitt is the first listed.
NCT06874322 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06874322 about?
NCT06874322 is a clinical study titled "Voiceitt for People With Impairments in Speech". The primary objective of this pilot study is to evaluate the feasibility and preliminary effectiveness of the Voiceitt app in improving communication for individuals with speech impairments due to conditions such as cerebral palsy (CP), stroke, Amyotrophic Lateral Sclerosis (ALS), or Parkinson's dis...
What is the current status of trial NCT06874322?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-06-25. Estimated completion is 2026-08.
What conditions does trial NCT06874322 study?
This clinical trial studies the following conditions: Speech Disorder, Speech Impairment.
What interventions are being tested in trial NCT06874322?
The interventions under investigation include: Voiceitt (OTHER).
Who is sponsoring clinical trial NCT06874322?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06874322 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Speech Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.